Kyli
New member
Hey everyone,
I'd like to ask for your input. My mother had Hodgkin's lymphoma. It started 8–9 years ago, and she went through hell—high-dose chemotherapy, radiation, a stem cell transplant, and more. For 5 years everything is fine. Now she's started feeling weaker, alongside GI problems (a chemically damaged esophagus), kidney problems, and high blood pressure.
After I had significant results with peptides myself, I suggested she look into some. On my shortlist for her were MOTS-c and BPC-157. But her research raised a concern: that both may carry cancer-related risks because they promote angiogenesis (new blood vessel growth).
Given her cancer history, this worries me. What's your experience or opinion on using these peptides in someone with a prior malignancy?
I'd like to ask for your input. My mother had Hodgkin's lymphoma. It started 8–9 years ago, and she went through hell—high-dose chemotherapy, radiation, a stem cell transplant, and more. For 5 years everything is fine. Now she's started feeling weaker, alongside GI problems (a chemically damaged esophagus), kidney problems, and high blood pressure.
After I had significant results with peptides myself, I suggested she look into some. On my shortlist for her were MOTS-c and BPC-157. But her research raised a concern: that both may carry cancer-related risks because they promote angiogenesis (new blood vessel growth).
Given her cancer history, this worries me. What's your experience or opinion on using these peptides in someone with a prior malignancy?